Russian Heart Failure Journal 2013year The issue of diagnosing chronic heart failure in real-life clinical practice

To access this material please log in or register

Register Authorize

The issue of diagnosing chronic heart failure in real-life clinical practice

Shtegman O. A., Petrova M. M., Polikarpov L. S., Vyrva P. V.

Keywords: diagnostics, CHF

DOI: 10.18087/rhfj.2013.4.1842

Background. In absence of clear signs for cardiac congestion, diagnosing CHF is a serious challenge for a clinician. Aim. To study causes for overdiagnosing CHF in the adult urban popylation visiting an outpatient clinic. Materials and methods. 378 patients with CVD complaining of shortness of breath were selected from 3,000 urban people older than 17. For all patients, echoCG, ECG, and 6min walk test (if not contraindicated) were performed. Depression was revealed using the questionnaire CES-D. Anxiety level was evaluated using the Spielberger questionnaire modified by Yu. L. Khanin. Final diagnosis of CHF was based on the presence of dyspnea, heart structure or function abnormality, and on the response to the treatment with drugs of the main group for CHF therapy. Results. CHF was documented in 63.8 % of 378 outpatient patients with CVD and dyspnea. One CHF patients had on average 1.35 additional causes for dyspnea. In outpatient patients without heart function disorders but with suspected CHF, among the causes for dyspnea, anxiety conditions were on the first place (53.3 %) and obesity on the second place (38.7 %) followed by detraining, respiratory organ abnormalities and anemia. Furthermore, a combination of different causes for dyspnea was observed in each third case. Conclusion. Causes for difficulties in CHF diagnostics in real-life clinical practice were analyzed.
  1. Lloyd-Jones D, Larson M, Leip E et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106 (24):3068–3072.
  2. Heidenreich PA, Trogdon JG, Khavjou OA et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123 (8):933–944.
  3. Oudejans I, Mosterd A, Bloemen JA et al. Clinical evaluation of geriatric outpatients with suspected heart failure: value of symptoms, signs, and additional tests. Eur J Heart Fail. 2011;13 (5):518–527.
  4. Fonseca C. Diagnosis of heart failure in primary care. Heart Fail Rev. 2006;11 (2):95–107.
  5. Мареев В. Ю., Даниелян М. О., Беленков Ю. Н. От имени рабочей группы исследования ЭПОХА–О–ХСН. Сравнительная характеристика больных с ХСН в зависимости от величины ФВ по результатам Российского многоцентрового исследования ЭПОХА–О–ХСН. Журнал Сердечная Недостаточность. 2006;7 (4):164–171.
  6. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2 (5):358–367.
  7. Devereux RB, Alonso DR, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy comparison to necropsy findings. Am J Cardiol. 1986;57 (6):450–458.
  8. Hammond IW, Devereux RB, Alderman MH et al. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol. 1986;7 (3):639–650.
  9. Nagueh SF, Appleton CP, Gillebert TC et al. Recommendations for the evaluation of left ventricular diastolic function by echocardio­graphy. J Am Soc Echocardiogr. 2009;22 (2):107–133.
  10. Paulus WJ, Tschope C, Sanderson JE et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007;28 (20):2539–2550.
  11. Dokainish H, Nguyen JS, Bobek J et al. Assessment of the American Society of Echocardiography-European Association of Echo­cardiography guidelines for diastolic function in patients with depressed ejection fraction: an echocardiographic and invasive haemodynamic study. Eur J Echocardiogr. 2011;12 (11):857–864.
  12. Lang RM, Bierig M, Devereux RB et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18 (12):1440–1463.
  13. Lang RM, Bierig M, Devereux RB et al. American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7 (2):79–108.
  14. Radloff LS. The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement. 1977;1:385–401.
  15. Ханин Ю. Л. Краткое руководство по применению Шкалы реактивной и личностной тревожности Ч. Д. Спилбергера. – Л.: ЛНИИФК, 1976. – 16 с.
  16. McMurray JJ, Adamopoulos S, Anker SD et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33 (14):1787–1847.
  17. Caroci Ade S, Lareau SC. Descriptors of dyspnea by patients with chronic obstructive pulmonary disease versus congestive heart failure. Heart Lung. 2004;33 (2):102–110.
  18. Seo JM, Park TH, Lee DY et al. Subclinical Myocardial Dysfunction in Metabolic Syndrome Patients without Hypertension. J Cardiovasc Ultrasound. 2011;19 (3):134–139.
  19. Andersen NH, Poulsen SH, Poulsen PL et al. Left ventricular dysfunction in hypertensive patients with Type 2 diabetes mellitus. Diabet Med. 2005;22 (9):1218–1225.
  20. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285 (26):1441–1446.
  21. Di Bari M, Pozzi C, Cavallini MC et al. The diagnosis of heart failure in the community. Comparative validation of four sets of criteria in unselected older adults: the ICARe Dicomano Study. J Am Coll Cardiol. 2004;44 (8):1601–1608.
  22. Schellenbaum GD, Rea TD, Heckbert SR et al. Survival associated with two sets of diagnostic criteria for congestive heart failure. Am J Epidemiol. 2004;160 (7):628–635.
  23. Hogg K, Swedberg K, McMurray J. Heart Failure with preserved left ventricular systolic function. Epidemiology, Clinical Characteristics, and Prognosis. J Am Coll Cardiol. 2004;43 (3):317–327.
  24. Штегман О. А., Терещенко Ю. А. Систолическая и диастолическая дисфункции левого желудочка – самостоятельные типы сердечной недостаточности или две стороны одного процесса? Кардиология. 2004;44 (2):82–86.
  25. Cowie MR, Jourdain P, Maisel A et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J. 2003;24 (19):1710–1718.
  26. Wang TJ, Larson MG, Levy D. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004 12;350 (7):655–663.
  27. Betti I, Castelli G, Barchielli A et al. The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study. J Card Fail. 2009;15 (5):377–384.
  28. Мареев В. Ю., Агеев Ф. Т., Арутюнов Г. П. и др. Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (третий пересмотр). Журнал Сердечная Недостаточность. 2010;11 (1):3–62.
  29. Kitzman DW, Gardin JM, Gottdiener JS et al. Importance of heart failure with preserved systolic function in patients 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol. 2001;87 (4):413–419.
  30. Rutten FH, Cramer MJM, Grobbee DE et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J. 2005;26 (18):1887–1894.
Shtegman O.A., Petrova M.M., Polikarpov L.S. et al. The issue of diagnosing chronic heart failure in real-life clinical practice. Russian Heart Failure Journal. 2013;14 (4):214-218

To access this material please log in or register

Register Authorize
Ru En